Alnylam Pharmaceuticals
ALNY
#581
Rank
A$55.24 B
Marketcap
$426.85
Share price
-0.94%
Change (1 day)
86.13%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $477.87 AUD on 2024-10-16

Lowest end of day price: $6.28 AUD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$21.97 0.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$1,013 0.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$111.95-1.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.70-2.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.75 15.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$178.99 1.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$88.75 1.66%๐Ÿ‡ซ๐Ÿ‡ท France
$23.98-2.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel